Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who give their consent to take part in the study
- For the glaucoma group: People who have primary open angle glaucoma in both eyes, meaning they have vision field damage caused by damage to the optic nerve
- For the comparison group: People who have no optic nerve problems, including no glaucoma
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who have sleep apnea
- People who have kidney problems or reduced kidney function
- People who have Parkinson's disease
- People who have Alzheimer's disease
- People who have antiphospholipid syndrome (a condition affecting the immune system and blood clotting)
- People who have had cancer and finished treatment less than 2 years ago
- People who have had a stroke less than 1 year ago
- People who have had a heart attack less than 1 year ago
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cédric LAMIREL, MD, Hôpital Fondation A. de Rothschild
Phone: 01 48 03 64 33
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Thickness of the Perfused boundary region (PBR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.